Aditxt, Inc. 2026 Annual Meeting: Key Shareholder Decisions and Price-Sensitive Information

Aditxt, Inc. (NASDAQ: ADTX), a company operating in the pharmaceutical preparations sector, held its 2026 annual meeting of stockholders on May 1, 2026. The meeting was conducted in a virtual-only format. Below is a detailed report of the matters submitted to a vote of security holders and other key information investors should be aware of.

Key Points from the 2026 Annual Meeting

• Participation: A total of 294,398 shares of Aditxt’s common stock, representing 34.17% of the outstanding shares, were present or represented at the meeting.
• Reverse Stock Split Proposal:
  • Shareholders approved a significant proposal granting the company’s Board of Directors discretionary authority to amend the Company’s certificate of incorporation to effect a reverse stock split of its outstanding common stock.
  • The approved reverse split ratio is within a broad range: anywhere from one-for-two (1:2) up to one-for-two hundred fifty (1:250). The precise ratio and timing of the split will be at the Board’s sole discretion, and the action can be taken at any time within one year of shareholder approval.
  • The voting outcome was as follows:
    • For: 205,568
    • Against: 84,351
    • Abstain: 4,479
    • Broker Non-Votes: 0
  • This is a highly price-sensitive action. A reverse stock split, especially at such high potential ratios, can significantly impact the share price, market capitalization, and the company’s compliance with Nasdaq’s listing requirements. Investors should watch for further announcements from the Board regarding the chosen ratio and effective date.
• Exchange and Trading Information:
  • The company’s common stock, par value \$0.001, trades under the symbol ADTX on the Nasdaq exchange.
  • As of the report, the company is not an emerging growth company under current SEC definitions.
• Other Regulatory Disclosures:
  • The company was not engaged in written communications under Rule 425, was not soliciting material, and was not involved in pre-commencement tender offers or issuer tender offers as of this filing.

Important Shareholder Information and Potential Price Sensitivities

• Reverse Stock Split: This is the most significant and potentially price-moving item from the meeting. Reverse stock splits are often executed to increase the per-share price, typically to maintain exchange listing standards or improve market perception. Given the wide range (1:2 to 1:250), the impact could be material—investors should closely monitor subsequent Board announcements.
• Future Advisory Votes on Executive Compensation:
  • The Board has also determined that future advisory votes regarding executive compensation (“say-on-pay”) will be held every three years unless otherwise required by future votes.
• Business Information Updates:
  • The company’s principal executive office address was updated to 737 N. Fifth Street, Suite 200, Richmond, VA 23219, but the phone number listed for the company is (650) 870-1200 and the mailing address is also in Richmond, VA.
  • The company’s Employer Identification Number (EIN) is 82-3204328.
  • The company has undergone two name changes in recent years, previously known as Aditx Therapeutics, Inc. and ADiTx Therapeutics, Inc.

Conclusion

The approval of the reverse stock split proposal is the dominant, potentially price-sensitive event for Aditxt, Inc. shareholders. Reverse stock splits can result in substantial changes to the company’s share structure and perceived value in the market. Investors should closely track further communications from the company regarding the split ratio and execution date, as these will directly impact share price and liquidity.

Disclaimer: This article is for informational purposes only and should not be considered investment advice. Investors are encouraged to consult with financial advisors and review official company filings before making investment decisions. The information above is based on the company’s filings and may be subject to change.

View Aditxt, Inc. Historical chart here